Literature DB >> 18440301

The effects of lipids on the structure of the eukaryotic cytolysin equinatoxin II: a synchrotron radiation circular dichroism spectroscopic study.

Andrew J Miles1, Alison Drechsler, Katarina Kristan, Gregor Anderluh, Raymond S Norton, B A Wallace, Frances Separovic.   

Abstract

Synchrotron radiation circular dichroism (SRCD) spectroscopy studies of the eukaryotic pore-forming protein equinatoxin II (EqtII) were carried out in solution and in the presence of micelles or small unilamellar vesicles (SUV) of different lipid composition. The SRCD structural data was correlated with calcein leakage from SUV and with partitioning of EqtII to liposomes, and micelles, according to haemolysis assays. The structure of EqtII in water and dodecylphosphocholine micelles as determined by SRCD was similar to the values calculated from crystal and solution structures of the protein, and no changes were observed with the addition of sphingomyelin (SM). SM is required to trigger pore formation in biological and model membranes, but our results suggest that SM alone is not sufficient to trigger dissociation of the N-terminal helix and further structural rearrangements required to produce a pore. Significant changes in conformation of EqtII were detected with unsaturated phospholipid (DOPC) vesicles when SM was added, but not with saturated phospholipids (DMPC), which suggests that not only is membrane curvature important, but also the fluidity of the bilayer. The SRCD data indicated that the EqtII structure in the presence of DOPC:SM SUV represents the 'bound' state and the 'free' state is represented by spectra for DOPC or DOPC:Chol vesicles, which correlates with the high lytic activity for SUV of DOPC:SM. The SRCD results provide insight into the lipid requirements for structural rearrangements associated with EqtII toxicity and lysis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18440301     DOI: 10.1016/j.bbamem.2008.04.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Characterization of the Lipid-Binding Site of Equinatoxin II by NMR and Molecular Dynamics Simulation.

Authors:  Daniel K Weber; Shenggen Yao; Nejc Rojko; Gregor Anderluh; Terry P Lybrand; Matthew T Downton; John Wagner; Frances Separovic
Journal:  Biophys J       Date:  2015-04-21       Impact factor: 4.033

Review 2.  Going deep into protein secondary structure with synchrotron radiation circular dichroism spectroscopy.

Authors:  Patricia S Kumagai; Ana P U Araujo; Jose L S Lopes
Journal:  Biophys Rev       Date:  2017-08-19

3.  Effect of lipid on the conformation of the N-terminal region of equinatoxin II: a synchrotron radiation circular dichroism spectroscopic study.

Authors:  Alison Drechsler; Andrew J Miles; Raymond S Norton; B A Wallace; Frances Separovic
Journal:  Eur Biophys J       Date:  2009-04-03       Impact factor: 1.733

4.  Purification and characterization of gigantoxin-4, a new actinoporin from the sea anemone Stichodactyla gigantea.

Authors:  Bo Hu; Wei Guo; Liang-Hua Wang; Jian-Guang Wang; Xiao-Yu Liu; Bing-Hua Jiao
Journal:  Int J Biol Sci       Date:  2011-06-07       Impact factor: 6.580

5.  Self-homodimerization of an actinoporin by disulfide bridging reveals implications for their structure and pore formation.

Authors:  Aisel Valle; Luis Benito Pérez-Socas; Liem Canet; Yadira de la Patria Hervis; German de Armas-Guitart; Diogo Martins-de-Sa; Jônatas Cunha Barbosa Lima; Adolfo Carlos Barros Souza; João Alexandre Ribeiro Gonçalves Barbosa; Sonia Maria de Freitas; Isabel Fabiola Pazos
Journal:  Sci Rep       Date:  2018-04-26       Impact factor: 4.379

6.  Chemical Synthesis and Characterization of an Equinatoxin II(1-85) Analogue.

Authors:  John A Karas; Marc-Antoine Sani; Frances Separovic
Journal:  Molecules       Date:  2017-03-30       Impact factor: 4.411

7.  Dissecting the mechanism of action of actinoporins. Role of the N-terminal amphipathic α-helix in membrane binding and pore activity of sticholysins I and II.

Authors:  Gustavo P B Carretero; Eduardo F Vicente; Eduardo M Cilli; Carlos M Alvarez; Håvard Jenssen; Shirley Schreier
Journal:  PLoS One       Date:  2018-08-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.